What Is Value in Health and Healthcare? A Systematic Literature Review of Value Assessment Frameworks

Zhang, Mengmeng; Bao, Yun; Lang, Yitian; Fu, Shihui; Kimber, Melissa; Levine, Mitchell; Xie, Feng

doi:10.1016/j.jval.2021.07.005

Cited by 12 publications

(23 citation statements)

References 77 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This study was conducted as part of the development of a VAF for HTA and coverage policymaking in China. We previously completed a systematic literature review to summarize existing VAFs, which informed the present study design [ 8 ]. This study focused on the identification and selection of value attributes for the VAF through incorporation of multiple stakeholders’ perspectives.…”

Section: Methodsmentioning

confidence: 99%

“…It is critical to engage them in the development of VAFs to align healthcare decisions with public preferences. However, the engagement of patients and members of the public was generally limited in existing VAFs [ 8 ]. Therefore, patients and participants recruited from the public (hereafter referred to as the public) are one of the key stakeholder groups for our study.…”

Section: Methodsmentioning

confidence: 99%

“…The second component of our analysis involved the use of multiple criteria to guide decisions related to retaining or dropping value attributes. The exclusion criteria were informed by the findings of our recently published systematic review of existing VAFs [ 8 ]. Some previous VAFs included societal context, such as political, historical and cultural milieu as contextual attributes and recommended measuring them qualitatively [ 8 , 16 , 40 – 42 ].…”

Section: Methodsmentioning

confidence: 99%

“…The exclusion criteria were informed by the findings of our recently published systematic review of existing VAFs [ 8 ]. Some previous VAFs included societal context, such as political, historical and cultural milieu as contextual attributes and recommended measuring them qualitatively [ 8 , 16 , 40 – 42 ]. However, the qualitative measurement methods for these attributes or the approaches of incorporating the measurement results of these attributes into the decision-making process were unknown or were not reported in these VAFs [ 8 , 16 , 40 – 42 ].…”

Section: Methodsmentioning

confidence: 99%

“…These VAFs facilitate transparent and consistent decision making, and promote the adoption and diffusion of innovative health technologies in healthcare systems [ 4 – 7 ]. However, most existing VAFs were developed for high-income countries [ 8 ]. There are a lack of VAFs developed in low- and middle-income countries that account for population preferences and limited resources available in the local setting.…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Identifying Attributes for a Value Assessment Framework in China: A Qualitative Study

et al. 2023

Self Cite

View full text Add to dashboard Cite

Background Value assessment frameworks (VAFs) are promising tools for measuring the value of health technologies and informing coverage policymaking; however, most published VAFs were developed for high-income countries. This study aimed to identify value attributes as part of the development of a VAF in China. Methods We used the qualitative description approach. Specifically, we conducted open-ended semi-structured interviews with Chinese stakeholders, as well as a review and analysis of publicly available government documents related to health technology assessment (HTA) and coverage policies in China. Conventional content analysis and the constant comparison technique were used to generate value attributes. Multiple criteria were used to determine the inclusion of a value attribute, with response levels of included attributes finalized via consensus meetings among the research team. Results Thirty-four stakeholders living or working in China completed the semi-structured interview. These stakeholders included policymakers ( n = 4), healthcare providers ( n = 8), HTA researchers ( n = 6), patients and members of the general public ( n = 9), and industry representatives ( n = 7). In addition, 16 government documents were included for analysis. Twelve value attributes grouped in eight categories are included in the VAF: (1) severity of disease; (2) health benefit, including survival, clinical outcomes, and patient-reported outcomes; (3) safety; (4) economic impact, including budget impact to payer and patients, and cost effectiveness; (5) innovation; (6) organizational impact; (7) health equity; and (8) quality of evidence. Conclusion These 12 value attributes were identified for the development of a VAF to support health technologies’ value assessment and coverage policymaking in China. Supplementary Information The online version contains supplementary material available at 10.1007/s40273-022-01235-6.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%